INBP
INTEGRATED BIOPHARMA INC
-0.01 (-5.56%)0.17USD4.0K成交股數5.3M市值–本益比(近四季)0.1股價營收比-27.5%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 10.1M-28% | 11.3M-11% | 12.7M-7% | 14.2M+8% | 13.9M+21% | 12.6M-2% | 13.6M+5% | 13.1M+0% | 11.5M | 12.9M | 13.0M | 13.1M |
| 營業成本 | 10.4M | 11.3M | 11.7M | 12.7M | 12.4M | 11.4M | 12.2M | 11.9M | 11.0M | 12.1M | 12.0M | 12.1M |
| 毛利 | −276K-118% | 29K-98% | 1.0M-26% | 1.5M+18% | 1.6M+198% | 1.2M+41% | 1.4M+39% | 1.2M+24% | 520K | 832K | 986K | 1.0M |
| 毛利率 | -2.7% | 0.3% | 8.0% | 10.4% | 11.1% | 9.3% | 10.1% | 9.5% | 4.5% | 6.4% | 7.6% | 7.7% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 809K | 943K | 856K | 880K | 812K | 969K | 881K | 893K | 972K | 886K | 907K | 964K |
| 營業利益 | −1.1M-247% | −914K-552% | 163K-67% | 589K+66% | 739K-263% | 202K-474% | 490K+520% | 355K+707% | −452K | −54K | 79K | 44K |
| 營業利益率 | -10.7% | -8.1% | 1.3% | 4.2% | 5.3% | 1.6% | 3.6% | 2.7% | -3.9% | -0.4% | 0.6% | 0.3% |
| 稅後淨利 | −837K-237% | −762K-757% | 123K-53% | −178K-162% | 611K-260% | 116K-297% | 259K+548% | 285K+1681% | −382K | −59K | 40K | 16K |
| 淨利率 | -8.3% | -6.8% | 1.0% | -1.3% | 4.4% | 0.9% | 1.9% | 2.2% | -3.3% | -0.5% | 0.3% | 0.1% |
| 稀釋 EPS | -0.03-250% | -0.03-400% | 0.00-100% | -0.01-200% | 0.02-300% | 0.01 | 0.01-133% | 0.01 | -0.01 | 0.00 | -0.03 | 0.00 |
| 稀釋股數 | 31.1M | 31.1M | 31.4M | 31.2M | 31.5M | 31.3M | 30.6M | 30.7M | 30.1M | 30.0M | 29.9M | 31.5M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.8M | 5.3M | 4.7M | 3.6M | 3.0M | 2.5M | 2.3M | 2.0M | 732K | 2.6M | 1.3M | 2.5M |
| 應收帳款 | 3.7M | 3.6M | 4.0M | 5.4M | 5.1M | 4.2M | 4.4M | 4.7M | 3.7M | 4.2M | 4.5M | 4.7M |
| 存貨 | 8.1M | 8.4M | 10.5M | 9.4M | 10.1M | 11.1M | 11.2M | 11.2M | 12.1M | 10.5M | 10.3M | 9.9M |
| 總資產 | 26.7M | 23.5M | 25.5M | 24.9M | 25.7M | 25.7M | 26.2M | 26.9M | 25.7M | 26.6M | 26.2M | 26.9M |
| 有息負債 | – | – | – | – | – | – | – | 0 | – | – | 7K | 18K |
| 總負債 | 7.7M | 3.8M | 5.1M | 4.6M | 5.3M | 5.9M | 6.6M | 8.0M | 7.2M | 7.8M | 6.6M | 8.1M |
| 股東權益 | 19.0M | 19.8M | 20.5M | 20.3M | 20.4M | 20K | 18.6M | 18.9M | 18.6M | 18.9M | 18.9M | 19K |
| 負債比 | 28.8% | 16.0% | 19.8% | 18.4% | 20.6% | 23.1% | 25.3% | 29.8% | 27.8% | 29.1% | 25.1% | 30.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | 2.0M | – | – | 1.3M | 2.5M |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | 1.3M+98% | – | – | – | 657K | – | – | 1.3M | – | – |
| 資本支出 | – | – | 173K | – | – | – | 56K | – | – | 38K | 18K | 16K |
| 自由現金流 | – | – | 1.1M+88% | – | – | – | 601K | – | – | 1.3M | – | – |
| 折舊攤銷 | – | – | 77K | – | – | – | 85K | – | – | 77K | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | 8.9% | – | – | – | 4.4% | – | – | 9.9% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 54.4M
| Contract Manufacturing | 51.7M | 95.1% | +6.4% |
|---|---|---|---|
| Other Nutraceutical Business | 2.7M | 4.9% | +52.7% |
地區2025 年度 · 54.4M
| 美國 | 43.6M | 80.3% | +3.0% |
|---|---|---|---|
| 美國以外 | 10.7M | 19.7% | +34.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 54.4M | +8.0% | 808K | 1.5% | 0.03 | 1.9M |
| FY2024 | 50.3M | -0.7% | 112K | 0.2% | 0.00 | 390K |
| FY2023 | 50.7M | -9.9% | −34K | -0.1% | 0.00 | 1.1M |
| FY2022 | 56.2M | -11.5% | 3.8M | 6.8% | 0.12 | 3.6M |
| FY2021 | 63.6M | +20.4% | 8.0M | 12.6% | 0.25 | 2.8M |
| FY2020 | 52.8M | +5.6% | 4.1M | 7.8% | 0.13 | 1.1M |
| FY2019 | 50.0M | – | 1.7M | 3.4% | 0.06 | −86K |